0001615219-22-000018.txt : 20220309
0001615219-22-000018.hdr.sgml : 20220309
20220309160155
ACCESSION NUMBER: 0001615219-22-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220303
FILED AS OF DATE: 20220309
DATE AS OF CHANGE: 20220309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arthur David J.
CENTRAL INDEX KEY: 0001769331
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36812
FILM NUMBER: 22725356
MAIL ADDRESS:
STREET 1: 2450 HOLCOME BLVD.
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001615219
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465087339
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2450 HOLCOMBE BLVD
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
BUSINESS PHONE: 346-772-0346
MAIL ADDRESS:
STREET 1: 2450 HOLCOMBE BLVD
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
FORMER COMPANY:
FORMER CONFORMED NAME: Flex Pharma, Inc.
DATE OF NAME CHANGE: 20140730
4
1
wf-form4_164685969931166.xml
FORM 4
X0306
4
2022-03-03
0
0001615219
Salarius Pharmaceuticals, Inc.
SLRX
0001769331
Arthur David J.
C/O SALARIUS PHARMACEUTICALS, INC.
2450 HOLCOME BLVD., SUITE X
HOUSTON
TX
77021
1
1
0
0
Chief Executive Officer
Common Stock
2022-03-03
4
P
0
139488
0.391
A
249674
D
The Registrant issued these shares to the reporting person as part of his bonus; which shares were issued in lieu of net cash compensation. The shares were issued at the fair market value of the Registrants common stock on the date of grant.
/s/Mark Rosenblum, as Attorney-in-Fact
2022-03-09